FDA Import Refusal SCS-2847296-0/21/1 — MR INNOVATION CO LTD
The FDA refused shipment SCS-2847296-0/21/1 from MR INNOVATION CO LTD (South Korea) on Aug 15, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Aug 15, 2022
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VAY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75